Impact of initial resectability and neoadjuvant chemotherapy on overall survival for pancreatic adenocarcinoma

被引：0
|
作者：
Poruk, Katherine E. [1 ]
Hyman, David [1 ]
Amairan, Alicia [1 ]
Zamorano, Gutierrez [1 ]
Tice, Mary [1 ]
Stauffer, John A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E230
引用
收藏
页码：S180 / S181
页数：2
相关论文
共 50 条
  • [1] Association of Adjuvant Chemotherapy with Overall Survival in Resected Pancreatic Adenocarcinoma Previously Treated with Neoadjuvant Therapy
    Swords, D. S.
    Garrido-Laguna, I.
    Mulvihill, S. J.
    Stoddard, G. J.
    Firpo, M. A.
    Scaife, C. L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S116 - S116
  • [2] Relationship between cholangitis, initial chemotherapy regimen, and overall survival in patients with unresectable pancreatic adenocarcinoma
    Lumish, Melissa
    Wang, Thomas
    Darnell, Elijah
    Hernandez-Barco, Yasmin
    Krishnan, Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
    Anne E. O’Shea
    Elizabeth L. Carpenter
    Daniel W. Nelson
    Timothy J. Vreeland
    [J]. Annals of Surgical Oncology, 2022, 29 : 6029 - 6030
  • [4] ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
    O'Shea, Anne E.
    Carpenter, Elizabeth L.
    Nelson, Daniel W.
    Vreeland, Timothy J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 6029 - 6030
  • [5] What is the Impact of Neoadjuvant Chemotherapy on Survival after Palliative Procedures for Pancreatic Ductal Adenocarcinoma?
    Halle-Smith, James
    Roberts, Keith
    [J]. BRITISH JOURNAL OF SURGERY, 2022, 109
  • [6] Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
    Schmocker, Ryan K.
    Delitto, Daniel
    Wright, Michael J.
    Ding, Ding
    Cameron, John L.
    Lafaro, Kelly J.
    Burns, William R.
    Wolfgang, Christopher L.
    Burkhart, Richard A.
    He, Jin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) : 405 - 413
  • [7] Association of adjuvant chemotherapy with overall survival in resected pancreatic adenocarcinoma previously treated with neoadjuvant therapy.
    Swords, Douglas S.
    Garrido-Laguna, Ignacio
    Mulvihill, Sean J.
    Stoddard, Gregory J.
    Firpo, Matthew A.
    Scaife, Courtney L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] The Role of Ferroptosis Signature in Overall Survival and Chemotherapy of Pancreatic Adenocarcinoma
    Wei, Wanhui
    Hu, Qian
    Li, Wenjie
    Li, Mengting
    Dong, Shouquan
    Peng, Yanan
    Yin, Jingwen
    Lu, Yuanyuan
    Liu, Lan
    Zhao, Qiu
    [J]. DNA AND CELL BIOLOGY, 2022, 41 (02) : 116 - 127
  • [9] Radiographic sarcopenia measurements to predict overall survival in patients with resectable pancreatic adenocarcinoma undergoing neoadjuvant chemotherapy.
    Zhang, Shuang Qin
    Roggin, Kevin K.
    Wroblewski, Kristen
    Kindler, Hedy L.
    Buschmann, Mary
    Dale, William
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
    O'Shea, A. E.
    Bohan, P. M. Kemp
    McCarthy, P. M.
    Adams, A. M.
    Bader, J. O.
    Krell, R. W.
    Peoples, G. E.
    Clifton, G. T.
    Nelson, D. W.
    Vreeland, T. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S98 - S98
12345